Editorial commentary: ACL tissue bioengineering clinical application is in its infancy.
Preclinical ACL tissue engineering studies show promise using a combination of cells, scaffolds, growth factors, and "stimulation," such as ultrasound or shockwave therapy, but clinical application is in its infancy. Bioactive scaffolds may be weak at time zero. A solution could be to add to the combination of cells, scaffolds, growth factors, simulation, and a structural tie.